These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11880655)
1. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Patel RC; Kumar U; Lamb DC; Eid JS; Rocheville M; Grant M; Rani A; Hazlett T; Patel SC; Gratton E; Patel YC Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3294-9. PubMed ID: 11880655 [TBL] [Abstract][Full Text] [Related]
2. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. Rocheville M; Lange DC; Kumar U; Sasi R; Patel RC; Patel YC J Biol Chem; 2000 Mar; 275(11):7862-9. PubMed ID: 10713101 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin and its receptor family. Patel YC Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861 [TBL] [Abstract][Full Text] [Related]
4. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785 [TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. Ozenberger BA; Hadcock JR Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136 [TBL] [Abstract][Full Text] [Related]
6. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis. Baragli A; Alturaihi H; Watt HL; Abdallah A; Kumar U Cell Signal; 2007 Nov; 19(11):2304-16. PubMed ID: 17706924 [TBL] [Abstract][Full Text] [Related]
7. Selective ligand recognition and activation of somatostatin receptors SSTR1 and SSTR3. Wang Y; Xu Y; Wang Y; Zhang J; Chen L; He X; Fan W; Wu K; Hu W; Cheng X; Yang G; Xu HE; Zhuang Y; Sun S Proc Natl Acad Sci U S A; 2024 Oct; 121(41):e2400298121. PubMed ID: 39361640 [TBL] [Abstract][Full Text] [Related]
8. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
9. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350 [TBL] [Abstract][Full Text] [Related]
10. Use of Fluorescence Indicators in Receptor Ligands. Harikumar KG; Miller LJ Methods Mol Biol; 2015; 1335():115-30. PubMed ID: 26260598 [TBL] [Abstract][Full Text] [Related]
11. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology. Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Watt HL; Kharmate GD; Kumar U Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659 [TBL] [Abstract][Full Text] [Related]
14. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus. Kumar U J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271 [TBL] [Abstract][Full Text] [Related]
15. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Zatelli MC; Piccin D; Vignali C; Tagliati F; Ambrosio MR; Bondanelli M; Cimino V; Bianchi A; Schmid HA; Scanarini M; Pontecorvi A; De Marinis L; Maira G; degli Uberti EC Endocr Relat Cancer; 2007 Mar; 14(1):91-102. PubMed ID: 17395978 [TBL] [Abstract][Full Text] [Related]
16. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Patel YC; Greenwood MT; Warszynska A; Panetta R; Srikant CB Biochem Biophys Res Commun; 1994 Jan; 198(2):605-12. PubMed ID: 7905265 [TBL] [Abstract][Full Text] [Related]
17. The two subtype 1 somatostatin receptors of rainbow trout, Tsst1A and Tsst1B, possess both distinct and overlapping ligand binding and agonist-induced regulation features. Gong JY; Kittilson JD; Slagter BJ; Sheridan MA Comp Biochem Physiol B Biochem Mol Biol; 2004 Jul; 138(3):295-303. PubMed ID: 15253878 [TBL] [Abstract][Full Text] [Related]
18. Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Nouel D; Gaudriault G; Houle M; Reisine T; Vincent JP; Mazella J; Beaudet A Endocrinology; 1997 Jan; 138(1):296-306. PubMed ID: 8977417 [TBL] [Abstract][Full Text] [Related]
19. The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors. Grant M; Patel RC; Kumar U J Biol Chem; 2004 Sep; 279(37):38636-43. PubMed ID: 15247250 [TBL] [Abstract][Full Text] [Related]
20. Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. Chen L; Hoeger C; Rivier J; Fitzpatrick VD; Vandlen RL; Tashjian AH Biochem Biophys Res Commun; 1999 May; 258(3):689-94. PubMed ID: 10329447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]